Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Polysaccharide Hemostatic Powder Market Research Report 2025

Global Polysaccharide Hemostatic Powder Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 80 Pages

Report ld: 3490591

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Polysaccharide Hemostatic Powder Market Size(US$)

CAGR 2025-2031

7.8%

Market Size,2031

USD 451

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 287 million

Market Forecast in 2031(Value)

US$ 451 million

CAGR

7.8%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Polysaccharide Hemostatic Powder was valued at US$ 269 million in the year 2024 and is projected to reach a revised size of US$ 451 million by 2031, growing at a CAGR of 7.8% during the forecast period.

A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Polysaccharide Hemostatic Powder is an innovative hemostatic product formulated primarily with natural polysaccharides, known for their ability to promote blood clotting and wound healing. As awareness of health and a demand for natural and safe products continue to rise, the market has shown a significant interest in Polysaccharide Hemostatic Powder. Its distinctive hemostatic mechanism and low irritability make it an ideal choice in fields such as surgical procedures, trauma management, and emergency care. In recent years, the clinical efficacy of Polysaccharide Hemostatic Powder has been well-documented, gradually establishing it as a trusted option among medical institutions and consumers alike.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Polysaccharide Hemostatic Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polysaccharide Hemostatic Powder.

The Polysaccharide Hemostatic Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polysaccharide Hemostatic Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polysaccharide Hemostatic Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

EndoClot Plus

Baxter

Hemostasis, LLC

Singclean Medical Products

Johnson & Johnson

Zhonghui Shengxi

Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.

Saikesaisi Holdings Group

Boz Medical

Segment by Type

Polysaccharide Hemostatic Powder

Absorbable Modified Polymer

Segment by Application

Hospital

Clinic

Other

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Polysaccharide Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Polysaccharide Hemostatic Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Polysaccharide Hemostatic Powder Market Overview

1.1 Product Definition

1.2 Polysaccharide Hemostatic Powder by Type

1.2.1 Global Polysaccharide Hemostatic Powder Market Value Comparison by Type (2024 VS 2031)

1.2.2 Polysaccharide Hemostatic Powder

1.2.3 Absorbable Modified Polymer

1.3 Polysaccharide Hemostatic Powder by Application

1.3.1 Global Polysaccharide Hemostatic Powder Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Polysaccharide Hemostatic Powder Market Size Estimates and Forecasts

1.4.1 Global Polysaccharide Hemostatic Powder Revenue 2020-2031

1.4.2 Global Polysaccharide Hemostatic Powder Sales 2020-2031

1.4.3 Global Polysaccharide Hemostatic Powder Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Polysaccharide Hemostatic Powder Market Competition by Manufacturers

2.1 Global Polysaccharide Hemostatic Powder Sales Market Share by Manufacturers (2020-2025)

2.2 Global Polysaccharide Hemostatic Powder Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Polysaccharide Hemostatic Powder Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Polysaccharide Hemostatic Powder, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Polysaccharide Hemostatic Powder, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Polysaccharide Hemostatic Powder, Product Type & Application

2.7 Global Key Manufacturers of Polysaccharide Hemostatic Powder, Date of Enter into This Industry

2.8 Global Polysaccharide Hemostatic Powder Market Competitive Situation and Trends

2.8.1 Global Polysaccharide Hemostatic Powder Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Polysaccharide Hemostatic Powder Players Market Share by Revenue

2.8.3 Global Polysaccharide Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Polysaccharide Hemostatic Powder Market Scenario by Region

3.1 Global Polysaccharide Hemostatic Powder Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Polysaccharide Hemostatic Powder Sales by Region: 2020-2031

3.2.1 Global Polysaccharide Hemostatic Powder Sales by Region: 2020-2025

3.2.2 Global Polysaccharide Hemostatic Powder Sales by Region: 2026-2031

3.3 Global Polysaccharide Hemostatic Powder Revenue by Region: 2020-2031

3.3.1 Global Polysaccharide Hemostatic Powder Revenue by Region: 2020-2025

3.3.2 Global Polysaccharide Hemostatic Powder Revenue by Region: 2026-2031

3.4 North America Polysaccharide Hemostatic Powder Market Facts & Figures by Country

3.4.1 North America Polysaccharide Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Polysaccharide Hemostatic Powder Sales by Country (2020-2031)

3.4.3 North America Polysaccharide Hemostatic Powder Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Polysaccharide Hemostatic Powder Market Facts & Figures by Country

3.5.1 Europe Polysaccharide Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Polysaccharide Hemostatic Powder Sales by Country (2020-2031)

3.5.3 Europe Polysaccharide Hemostatic Powder Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Polysaccharide Hemostatic Powder Market Facts & Figures by Region

3.6.1 Asia Pacific Polysaccharide Hemostatic Powder Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Polysaccharide Hemostatic Powder Sales by Region (2020-2031)

3.6.3 Asia Pacific Polysaccharide Hemostatic Powder Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Polysaccharide Hemostatic Powder Market Facts & Figures by Country

3.7.1 Latin America Polysaccharide Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Polysaccharide Hemostatic Powder Sales by Country (2020-2031)

3.7.3 Latin America Polysaccharide Hemostatic Powder Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Polysaccharide Hemostatic Powder Market Facts & Figures by Country

3.8.1 Middle East and Africa Polysaccharide Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Polysaccharide Hemostatic Powder Sales by Country (2020-2031)

3.8.3 Middle East and Africa Polysaccharide Hemostatic Powder Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Polysaccharide Hemostatic Powder Sales by Type (2020-2031)

4.1.1 Global Polysaccharide Hemostatic Powder Sales by Type (2020-2025)

4.1.2 Global Polysaccharide Hemostatic Powder Sales by Type (2026-2031)

4.1.3 Global Polysaccharide Hemostatic Powder Sales Market Share by Type (2020-2031)

4.2 Global Polysaccharide Hemostatic Powder Revenue by Type (2020-2031)

4.2.1 Global Polysaccharide Hemostatic Powder Revenue by Type (2020-2025)

4.2.2 Global Polysaccharide Hemostatic Powder Revenue by Type (2026-2031)

4.2.3 Global Polysaccharide Hemostatic Powder Revenue Market Share by Type (2020-2031)

4.3 Global Polysaccharide Hemostatic Powder Price by Type (2020-2031)

5 Segment by Application

5.1 Global Polysaccharide Hemostatic Powder Sales by Application (2020-2031)

5.1.1 Global Polysaccharide Hemostatic Powder Sales by Application (2020-2025)

5.1.2 Global Polysaccharide Hemostatic Powder Sales by Application (2026-2031)

5.1.3 Global Polysaccharide Hemostatic Powder Sales Market Share by Application (2020-2031)

5.2 Global Polysaccharide Hemostatic Powder Revenue by Application (2020-2031)

5.2.1 Global Polysaccharide Hemostatic Powder Revenue by Application (2020-2025)

5.2.2 Global Polysaccharide Hemostatic Powder Revenue by Application (2026-2031)

5.2.3 Global Polysaccharide Hemostatic Powder Revenue Market Share by Application (2020-2031)

5.3 Global Polysaccharide Hemostatic Powder Price by Application (2020-2031)

6 Key Companies Profiled

6.1 EndoClot Plus

6.1.1 EndoClot Plus Company Information

6.1.2 EndoClot Plus Description and Business Overview

6.1.3 EndoClot Plus Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.1.4 EndoClot Plus Polysaccharide Hemostatic Powder Product Portfolio

6.1.5 EndoClot Plus Recent Developments/Updates

6.2 Baxter

6.2.1 Baxter Company Information

6.2.2 Baxter Description and Business Overview

6.2.3 Baxter Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Baxter Polysaccharide Hemostatic Powder Product Portfolio

6.2.5 Baxter Recent Developments/Updates

6.3 Hemostasis, LLC

6.3.1 Hemostasis, LLC Company Information

6.3.2 Hemostasis, LLC Description and Business Overview

6.3.3 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Hemostasis, LLC Polysaccharide Hemostatic Powder Product Portfolio

6.3.5 Hemostasis, LLC Recent Developments/Updates

6.4 Singclean Medical Products

6.4.1 Singclean Medical Products Company Information

6.4.2 Singclean Medical Products Description and Business Overview

6.4.3 Singclean Medical Products Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Singclean Medical Products Polysaccharide Hemostatic Powder Product Portfolio

6.4.5 Singclean Medical Products Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Company Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Johnson & Johnson Polysaccharide Hemostatic Powder Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

6.6 BD

6.6.1 BD Company Information

6.6.2 BD Description and Business Overview

6.6.3 BD Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.6.4 BD Polysaccharide Hemostatic Powder Product Portfolio

6.6.5 BD Recent Developments/Updates

6.7 Zhonghui Shengxi

6.7.1 Zhonghui Shengxi Company Information

6.7.2 Zhonghui Shengxi Description and Business Overview

6.7.3 Zhonghui Shengxi Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Zhonghui Shengxi Polysaccharide Hemostatic Powder Product Portfolio

6.7.5 Zhonghui Shengxi Recent Developments/Updates

6.8 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.

6.8.1 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Company Information

6.8.2 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Description and Business Overview

6.8.3 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Product Portfolio

6.8.5 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Developments/Updates

6.9 Saikesaisi Holdings Group

6.9.1 Saikesaisi Holdings Group Company Information

6.9.2 Saikesaisi Holdings Group Description and Business Overview

6.9.3 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Product Portfolio

6.9.5 Saikesaisi Holdings Group Recent Developments/Updates

6.10 Boz Medical

6.10.1 Boz Medical Company Information

6.10.2 Boz Medical Description and Business Overview

6.10.3 Boz Medical Polysaccharide Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Boz Medical Polysaccharide Hemostatic Powder Product Portfolio

6.10.5 Boz Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Polysaccharide Hemostatic Powder Industry Chain Analysis

7.2 Polysaccharide Hemostatic Powder Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Polysaccharide Hemostatic Powder Production Mode & Process Analysis

7.4 Polysaccharide Hemostatic Powder Sales and Marketing

7.4.1 Polysaccharide Hemostatic Powder Sales Channels

7.4.2 Polysaccharide Hemostatic Powder Distributors

7.5 Polysaccharide Hemostatic Powder Customer Analysis

8 Polysaccharide Hemostatic Powder Market Dynamics

8.1 Polysaccharide Hemostatic Powder Industry Trends

8.2 Polysaccharide Hemostatic Powder Market Drivers

8.3 Polysaccharide Hemostatic Powder Market Challenges

8.4 Polysaccharide Hemostatic Powder Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Polysaccharide Hemostatic Powder Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Polysaccharide Hemostatic Powder Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Polysaccharide Hemostatic Powder Market Competitive Situation by Manufacturers in 2024

Table 4. Global Polysaccharide Hemostatic Powder Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Polysaccharide Hemostatic Powder Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Polysaccharide Hemostatic Powder Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Polysaccharide Hemostatic Powder Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Polysaccharide Hemostatic Powder Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Polysaccharide Hemostatic Powder, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Polysaccharide Hemostatic Powder, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Polysaccharide Hemostatic Powder, Product Type & Application

Table 12. Global Key Manufacturers of Polysaccharide Hemostatic Powder, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Polysaccharide Hemostatic Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic Powder as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Polysaccharide Hemostatic Powder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Polysaccharide Hemostatic Powder Sales by Region (2020-2025) & (K Units)

Table 18. Global Polysaccharide Hemostatic Powder Sales Market Share by Region (2020-2025)

Table 19. Global Polysaccharide Hemostatic Powder Sales by Region (2026-2031) & (K Units)

Table 20. Global Polysaccharide Hemostatic Powder Sales Market Share by Region (2026-2031)

Table 21. Global Polysaccharide Hemostatic Powder Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Polysaccharide Hemostatic Powder Revenue Market Share by Region (2020-2025)

Table 23. Global Polysaccharide Hemostatic Powder Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Polysaccharide Hemostatic Powder Revenue Market Share by Region (2026-2031)

Table 25. North America Polysaccharide Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Polysaccharide Hemostatic Powder Sales by Country (2020-2025) & (K Units)

Table 27. North America Polysaccharide Hemostatic Powder Sales by Country (2026-2031) & (K Units)

Table 28. North America Polysaccharide Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Polysaccharide Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Polysaccharide Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Polysaccharide Hemostatic Powder Sales by Country (2020-2025) & (K Units)

Table 32. Europe Polysaccharide Hemostatic Powder Sales by Country (2026-2031) & (K Units)

Table 33. Europe Polysaccharide Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Polysaccharide Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Polysaccharide Hemostatic Powder Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Polysaccharide Hemostatic Powder Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Polysaccharide Hemostatic Powder Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Polysaccharide Hemostatic Powder Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Polysaccharide Hemostatic Powder Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Polysaccharide Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Polysaccharide Hemostatic Powder Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Polysaccharide Hemostatic Powder Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Polysaccharide Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Polysaccharide Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Polysaccharide Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Polysaccharide Hemostatic Powder Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Polysaccharide Hemostatic Powder Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Polysaccharide Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Polysaccharide Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Polysaccharide Hemostatic Powder Sales (K Units) by Type (2020-2025)

Table 51. Global Polysaccharide Hemostatic Powder Sales (K Units) by Type (2026-2031)

Table 52. Global Polysaccharide Hemostatic Powder Sales Market Share by Type (2020-2025)

Table 53. Global Polysaccharide Hemostatic Powder Sales Market Share by Type (2026-2031)

Table 54. Global Polysaccharide Hemostatic Powder Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Polysaccharide Hemostatic Powder Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Polysaccharide Hemostatic Powder Revenue Market Share by Type (2020-2025)

Table 57. Global Polysaccharide Hemostatic Powder Revenue Market Share by Type (2026-2031)

Table 58. Global Polysaccharide Hemostatic Powder Price (US$/Unit) by Type (2020-2025)

Table 59. Global Polysaccharide Hemostatic Powder Price (US$/Unit) by Type (2026-2031)

Table 60. Global Polysaccharide Hemostatic Powder Sales (K Units) by Application (2020-2025)

Table 61. Global Polysaccharide Hemostatic Powder Sales (K Units) by Application (2026-2031)

Table 62. Global Polysaccharide Hemostatic Powder Sales Market Share by Application (2020-2025)

Table 63. Global Polysaccharide Hemostatic Powder Sales Market Share by Application (2026-2031)

Table 64. Global Polysaccharide Hemostatic Powder Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Polysaccharide Hemostatic Powder Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Polysaccharide Hemostatic Powder Revenue Market Share by Application (2020-2025)

Table 67. Global Polysaccharide Hemostatic Powder Revenue Market Share by Application (2026-2031)

Table 68. Global Polysaccharide Hemostatic Powder Price (US$/Unit) by Application (2020-2025)

Table 69. Global Polysaccharide Hemostatic Powder Price (US$/Unit) by Application (2026-2031)

Table 70. EndoClot Plus Company Information

Table 71. EndoClot Plus Description and Business Overview

Table 72. EndoClot Plus Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. EndoClot Plus Polysaccharide Hemostatic Powder Product

Table 74. EndoClot Plus Recent Developments/Updates

Table 75. Baxter Company Information

Table 76. Baxter Description and Business Overview

Table 77. Baxter Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Baxter Polysaccharide Hemostatic Powder Product

Table 79. Baxter Recent Developments/Updates

Table 80. Hemostasis, LLC Company Information

Table 81. Hemostasis, LLC Description and Business Overview

Table 82. Hemostasis, LLC Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Hemostasis, LLC Polysaccharide Hemostatic Powder Product

Table 84. Hemostasis, LLC Recent Developments/Updates

Table 85. Singclean Medical Products Company Information

Table 86. Singclean Medical Products Description and Business Overview

Table 87. Singclean Medical Products Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Singclean Medical Products Polysaccharide Hemostatic Powder Product

Table 89. Singclean Medical Products Recent Developments/Updates

Table 90. Johnson & Johnson Company Information

Table 91. Johnson & Johnson Description and Business Overview

Table 92. Johnson & Johnson Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Johnson & Johnson Polysaccharide Hemostatic Powder Product

Table 94. Johnson & Johnson Recent Developments/Updates

Table 95. BD Company Information

Table 96. BD Description and Business Overview

Table 97. BD Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. BD Polysaccharide Hemostatic Powder Product

Table 99. BD Recent Developments/Updates

Table 100. Zhonghui Shengxi Company Information

Table 101. Zhonghui Shengxi Description and Business Overview

Table 102. Zhonghui Shengxi Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Zhonghui Shengxi Polysaccharide Hemostatic Powder Product

Table 104. Zhonghui Shengxi Recent Developments/Updates

Table 105. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Company Information

Table 106. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Description and Business Overview

Table 107. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Product

Table 109. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Developments/Updates

Table 110. Saikesaisi Holdings Group Company Information

Table 111. Saikesaisi Holdings Group Description and Business Overview

Table 112. Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Product

Table 114. Saikesaisi Holdings Group Recent Developments/Updates

Table 115. Boz Medical Company Information

Table 116. Boz Medical Description and Business Overview

Table 117. Boz Medical Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Boz Medical Polysaccharide Hemostatic Powder Product

Table 119. Boz Medical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Polysaccharide Hemostatic Powder Distributors List

Table 123. Polysaccharide Hemostatic Powder Customers List

Table 124. Polysaccharide Hemostatic Powder Market Trends

Table 125. Polysaccharide Hemostatic Powder Market Drivers

Table 126. Polysaccharide Hemostatic Powder Market Challenges

Table 127. Polysaccharide Hemostatic Powder Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Polysaccharide Hemostatic Powder

Figure 2. Global Polysaccharide Hemostatic Powder Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Polysaccharide Hemostatic Powder Market Share by Type: 2024 & 2031

Figure 4. Polysaccharide Hemostatic Powder Product Picture

Figure 5. Absorbable Modified Polymer Product Picture

Figure 6. Global Polysaccharide Hemostatic Powder Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Polysaccharide Hemostatic Powder Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Polysaccharide Hemostatic Powder Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Polysaccharide Hemostatic Powder Market Size (2020-2031) & (US$ Million)

Figure 13. Global Polysaccharide Hemostatic Powder Sales (2020-2031) & (K Units)

Figure 14. Global Polysaccharide Hemostatic Powder Average Price (US$/Unit) & (2020-2031)

Figure 15. Polysaccharide Hemostatic Powder Report Years Considered

Figure 16. Polysaccharide Hemostatic Powder Sales Share by Manufacturers in 2024

Figure 17. Global Polysaccharide Hemostatic Powder Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Polysaccharide Hemostatic Powder Players: Market Share by Revenue in Polysaccharide Hemostatic Powder in 2024

Figure 19. Polysaccharide Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Polysaccharide Hemostatic Powder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Polysaccharide Hemostatic Powder Sales Market Share by Country (2020-2031)

Figure 22. North America Polysaccharide Hemostatic Powder Revenue Market Share by Country (2020-2031)

Figure 23. United States Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Polysaccharide Hemostatic Powder Sales Market Share by Country (2020-2031)

Figure 26. Europe Polysaccharide Hemostatic Powder Revenue Market Share by Country (2020-2031)

Figure 27. Germany Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Polysaccharide Hemostatic Powder Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Polysaccharide Hemostatic Powder Revenue Market Share by Region (2020-2031)

Figure 34. China Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Polysaccharide Hemostatic Powder Sales Market Share by Country (2020-2031)

Figure 44. Latin America Polysaccharide Hemostatic Powder Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Polysaccharide Hemostatic Powder Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Polysaccharide Hemostatic Powder Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Polysaccharide Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Polysaccharide Hemostatic Powder by Type (2020-2031)

Figure 54. Global Revenue Market Share of Polysaccharide Hemostatic Powder by Type (2020-2031)

Figure 55. Global Polysaccharide Hemostatic Powder Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Polysaccharide Hemostatic Powder by Application (2020-2031)

Figure 57. Global Revenue Market Share of Polysaccharide Hemostatic Powder by Application (2020-2031)

Figure 58. Global Polysaccharide Hemostatic Powder Price (US$/Unit) by Application (2020-2031)

Figure 59. Polysaccharide Hemostatic Powder Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Polysaccharide Hemostatic Powder market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Polysaccharide Hemostatic Powder market is 7.8% 2025 to 2031.

Which companies rank high in the global Polysaccharide Hemostatic Powder market? shouQi

What was the global market size of Polysaccharide Hemostatic Powder in 2025? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Polysaccharide Hemostatic Powder in 2031? shouQi

Related Reports

Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 287 million in 2025 and is projected to reach US$ 483 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2026
The global Polysaccharide Hemostatic Powder market was valued at US$ 287 million in 2025 and is anticipated to reach US$ 483 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 110
USD 2900.00
(Single User License)
Global Polysaccharide Hemostatic Powder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polysaccharide Hemostatic Powder market size was US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 77
USD 4250.00
(Single User License)
Global Polysaccharide Hemostatic Powder Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Polysaccharide Hemostatic Powder market is projected to grow from US$ 269 million in 2024 to US$ 451 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 150
USD 4900.00
(Single User License)
Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 106
USD 3950.00
(Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2024
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)

Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 287 million in 2025 and is projected to reach US$ 483 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 128
USD 3950.00 (Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2026
The global Polysaccharide Hemostatic Powder market was valued at US$ 287 million in 2025 and is anticipated to reach US$ 483 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 110
USD 2900.00 (Single User License)
Global Polysaccharide Hemostatic Powder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polysaccharide Hemostatic Powder market size was US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 77
USD 4250.00 (Single User License)
Global Polysaccharide Hemostatic Powder Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Polysaccharide Hemostatic Powder market is projected to grow from US$ 269 million in 2024 to US$ 451 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 150
USD 4900.00 (Single User License)
Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 106
USD 3950.00 (Single User License)
Global Polysaccharide Hemostatic Powder Market Research Report 2024
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
Published: 2024-01-17
Pages: 91
USD 2900.00 (Single User License)